Indications and Outcomes for Temporary Mechanical Circulatory Support in Pediatric Patients with Cardiac Failure

David W Bearl1, Robert D B Jaquiss2, Travis P Vesel3

  • 1From the Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|December 14, 2018
PubMed

Insights

Temporary continuous-flow ventricular assist devices (cfVAD) offer longer support for pediatric patients than extracorporeal membrane oxygenation (ECMO), facilitating recovery, durable VAD transition, or transplant.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Cardiovascular Surgery

Background:

  • Temporary mechanical circulatory support is crucial for pediatric patients with severe heart failure.
  • Continuous-flow ventricular assist devices (cfVAD) and extracorporeal membrane oxygenation (ECMO) are primary options.
  • Limited pediatric literature exists for temporary cfVAD use.

Purpose of the Study:

  • To compare the outcomes of temporary cfVAD and ECMO in pediatric patients.
  • To evaluate the duration of support and patient disposition for each device.
  • To assess the role of temporary cfVAD as a bridge to durable VAD or transplant.

Main Methods:

  • Single-center retrospective review of pediatric patients (<19 years) from January 2011 to June 2016.
  • Comparison of 13 patients receiving temporary cfVAD with 11 patients receiving ECMO for similar indications.
  • Analysis of precannulation data, duration of support, and patient outcomes (recovery, transplant, death).

Main Results:

  • Median cfVAD support duration was 20 days (range 6-227) vs. 9 days (range 1-15) for ECMO.
  • cfVAD patients: 1 recovered, 6 transplanted, 6 died.
  • ECMO patients: 5 recovered, 3 transplanted after durable VAD conversion, 3 died. No direct ECMO-to-transplant.
  • No significant difference in precannulation data, except higher lactate and lower pH in ECMO cohort.

Conclusions:

  • Temporary cfVAD can provide longer mechanical circulatory support in pediatric patients compared to ECMO.
  • cfVAD facilitates transition to durable VAD and subsequent heart transplantation.
  • cfVAD represents a viable option for pediatric mechanical circulatory support, improving outcomes and bridging to definitive therapy.

Related Concept Videos

Mechanical Ventilation I: Indication and Settings01:29

Mechanical Ventilation I: Indication and Settings

Mechanical ventilation is a life-saving technique for managing acute respiratory failure and other respiratory complications. The process involves using a machine known as a ventilator to supply oxygen to the lungs and assist in removing carbon dioxide. It serves as a bridge to long-term mechanical ventilation or a temporary measure until ventilatory support is discontinued. The ventilator can maintain this function for a prolonged period, providing critical support for patients until they can...
2.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Indicators02:39

Indicators

Certain organic substances change color in dilute solution when the hydronium ion concentration reaches a particular value. For example, phenolphthalein is a colorless substance in any aqueous solution with a hydronium ion concentration greater than 5.0 × 10−9 M (pH < 8.3). In more basic solutions where the hydronium ion concentration is less than 5.0 × 10−9 M (pH > 8.3), it is red or pink. Substances such as phenolphthalein, which can be used to determine the pH of a solution, are...
60.7K
Anatomy of the Circulatory System02:03

Anatomy of the Circulatory System

The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
98.0K